학술논문
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study
Document Type
Article
Author
Source
In: Annals of Surgical Oncology . (Annals of Surgical Oncology, March 2024, 31(3):1919-1932)
Subject
Language
English
ISSN
15344681
10689265
10689265